Trulieve Announces Grand Opening of its Affiliate's (Chamounix Ventures, LLC) Philadelphia Dispensary – Clearfield Progress
TALLAHASSEE, Fla., Jan. 7, 2022 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the opening of a new Trulieve-branded medical marijuana dispensary through its affiliate, Chamounix Ventures, LLC. The dispensary at 1222 Arch St. is in the Center City section of Philadelphia. This location becomes the Company’s 160th owned, operated or affiliated dispensary nationwide.
Located in the heart of Philadelphia, between City Hall and Reading Terminal Market, the dispensary will be open Monday – Saturday from 9am – 8pm and on Sunday from 10am – 6pm. Patients can choose from Trulieve’s selection of premium whole flower products, including TruFlower and Cultivar Collection, as well as a wide range of vapes, tinctures, topicals and ingestibles.
“We are proud to begin the New Year by demonstrating our ongoing commitment to serving Pennsylvania’s patient community through high quality and reliable medical marijuana products,” said Kim Rivers, CEO of Trulieve. “We look forward to welcoming patients and strengthening community connections in this cornerstone market.”
Additional Trulieve-affiliated dispensaries in Pennsylvania are located in Camp Hill, Cranberry Township, Devon, Harrisburg, Johnstown, King of Prussia, Pittsburgh, Reading, Scranton, Washington, Whitehall, York and Zelienople.